期刊文献+

生物人工肾小管对多器官功能衰竭细胞因子及存活时间的影响 被引量:1

Effect of bioartificial renal tubule on IL-10,TNF-áand survival time in pigs with MOF
原文传递
导出
摘要 目的研究用细胞株(LLC-PK1)构建的生物人工肾小管装置(RAD)对多器官功能衰竭(MOF)猪白介素(IL)-10、肿瘤坏死因子(TNF)α及存活时间的影响。方法ARF并MOF猪随机分为3组:(1)RAD组(A组,n=5):将RAD与血滤器相连,行连续静脉静脉血液滤过(CVVH)治疗24h;(2)假RAD组(B组,n=5):将RAD换为无细胞的假RAD,余与A组同;(3)未治疗组(C组,n=6)。观察血压、肝肾功能、血气、血IL-10、TNF-α(用特异性猪IL-10、TNF-α抗体检测)和生存时间。结果(1)A组治疗24h低血压状况显著改善;4~20h精神状态明显好转。(2)血IL-10(pg/ml)的峰值A组明显高于B、C组(241.40±86.64比106.30±9.69、102.59±10.21,P<0.05)。(3)血TNF-α(pg/ml)A组治疗后较治疗前明显降低(415.30±34.83比526.67±40.08,P<0.05);B、C两组无明显变化。(4)A组生存时间为(110.25±18.69)h,明显长于B组(81.20±11.76)h和C组(74.96±23.00)h(P<0.05),A组比B、C组分别延长了35.8%、47.1%。结论用RAD治疗明显改善了MOF猪低血压,升高血IL-10、降低TNF-α及延长存活时间。 Objective To investigate the effect of bioartificial renal tubul e assist device(RAD) on IL-10,TNF-á, biochemistry indexes, and survival time in pigs with multiple organ failure(MOF). Methods Pigs suffered from ARF and MOF w ere treated with RAD(A group,n=5) or sham RAD containing no cells(B group,n=5) o r received no treatment(C group,n=6). Blood pressure,hepatic and renal function, IL-10,TNF-á,arterial blood gas and survival time of all three groups were re corded periodically. Results (1)MAP responed more rapidly and reached higher val ues in group A compared to group B or C after 24 hours of the treatment. (2)The peak level of serum IL-10 in group A was significantly higher than those in gro up B or group C(241.40±86.64 vs 106.30±9.69 or 102.59±10.21,pg/ml,P< 0.05). ( 3)Serum TNF-álevel in group A dropped gradually to (415.30 after 24 hours, and had significant discrepancy compared to those before treatment [( 526.67±40.08)pg/ml] and those in group B(P< 0.05). (4)The average survival tim e in group A was significantly longer [(110.25±18.69)h] than that in the group B[(81.20±11.76)h] or group C[(74.96±23.00)h](P< 0.05),which was prolonged by 3 5.8%and 47.1%,respectively. Conclusion Treatment with RAD can prolong the surv ival time of MOF,possibly through increasing the level of IL-10 and decreasing the level of TNF-á.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2004年第4期286-289,共4页 Chinese Journal of Nephrology
基金 国家自然科学基金(30170433)
关键词 生物人工肾小管 多器官功能衰竭 细胞因子 存活时间 LLC-PK1 RAD 肿瘤坏死因子α Bioartificial organs Interleukin 10 Tumor necrosis factor-á Renal tubule Multiple organ failure Survival time
  • 相关文献

参考文献11

  • 1Humes HD, Mackay SM, Funke A J, et al. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kindey Int, 1999,55: 2502-2514.
  • 2应旭旻,王笑云,沈霞.生物人工肾小管体外构建的研究[J].南京医科大学学报(自然科学版),2001,21(3):263-265. 被引量:11
  • 3王恒进,王笑云,应旭旻,毛慧娟,沈霞.猪多器官功能障碍综合征合并急性肾衰竭模型的制作[J].南京医科大学学报(自然科学版),2003,23(3):196-199. 被引量:8
  • 4Humes HD, Buffington DA, MacKay SM, et al. Replacement of renal function in uremic animals with a tissue-engineered kidney.Nat Biotechnol, 1999, 17: 451-455.
  • 5Lange H. Multiorgan dysfunction syndrome: how water might contribute to its progression. J Cell Mol Med, 2002, 6: 653-660.
  • 6Lally K, Cruz E, Xue H. The role of anti-tumor necrosis factor-αand interleukin-10 in protecting murine neonates from Escherichia coli sepsis. J Pediatr Surg, 2000, 35: 852-854.
  • 7Matsumoto T, Tateda K, Miyasaki S, et al. Effect of intedeukin-10on gut-derived sepsis caused by pseudomonas aeruginosa in mice.Antimicrob Agents Chemother, 1998, 42: 2853-2857.
  • 8Ferrer TJ, Webb JW, Wallace BH, et al. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfuntion syndrome(MODS). J Surg Res, 1998, 77: 157-164.
  • 9Latifi SQ, O'Riordan MA, Levine AD. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun, 2002, 70:4441-4446.
  • 10Kielar M, Jeyarajah DR, Lu CY. The regulation of ischemic acute renal failure by extrarenal organs. Curr Opin Nephrol Hypertens,2002, 11: 451-457.

二级参考文献16

  • 1应旭晏.急性肾衰竭并多脏器衰竭的诊断[A].王笑云.急性肾衰竭现代诊疗[C].南京:江苏科学技术出版社,2001.211-223.
  • 2林善锬.急性肾衰竭[A].叶任高.内科学 第5版[C].北京:人民卫生出版社,2000.562—568.
  • 3[1]Douma CE,Redekop WK, van der Meulen JH, et al.Predicting morta lity in intensive care patients with acute renal failure treated with dialysis[ J]. J Am Soc Nephrol,1997,8(1):111-117.
  • 4[2]Blantz RC. Filtration,reabsorption and oxygen in the kidney[J]. Adv Exp Med Biol,1994,361:579-584.
  • 5[3]Frank J,Engler-Blum G, Rodemann HP,et al. Human renal tubular cells as a cytokine sourse:PDGF-6,GM-CSF and IL-6 mRNA expression in vitro[J]. Exp Nephrol, 1993,1:26-35.
  • 6[4]Kresse S, Schlee H,Deuber HJ, et al. Influence of renal replacement t herapy on outcome of patients with acute renal failure[J]. Kidney Int, 1999,56 (Suppl 72):75-78.
  • 7[5]McCarthy JT. Renal replacement therapy in acute renal failure[J]. Curr Opin Nephrol Hypertens, 1996,5(6):480-484.
  • 8[6]Humes HD. Krauss JC, Cieslinski DA, et al. Tubulogenesis from isolate d single cells of adult mammalian kidney:clonal analysis with a recombinant retrovirus[J]. Am J Physiol,1996,271:F42-49.
  • 9[7]Humes HD, Mackay SM, Funke AJ, et al.The bioartificial renal tubule a ssist device to enhance CRRT in acute renal failure[J]. Am J Kidney Dis,1997,( Suppl):S28-31.
  • 10[8]Mackay SM, Funke AJ, Buffington DA, et al. Tissule engineering of a b ioartificial renal tubule[J]. ASAIO J,1998,44(3):179-183.

共引文献45

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部